BioCentury | May 5, 2014
Company News

Magellan BioScience, Sirona Biochem deal

...financial terms will be determined on a project-basis. Magellan could not be reached for details. Magellan BioScience Group Inc....
BioCentury | Jul 25, 2011
Company News

Magellan Bio, Thermo Fisher deal

Magellan sold its TREK Diagnostic Systems to Thermo Fisher for an undisclosed sum. TREK includes automated blood culture, microbial identification and microbial susceptibility testing platforms. Magellan said it will focus on its LeadCare business, which...
BioCentury | Apr 18, 2011
Company News

Magellan Bio, miacom diagnostics GmbH sales and marketing update

Magellan received exclusive commercialization rights to miacom's Bacteremia and Fungimia panels in the U.S. and Canada to identify sepsis-related pathogens for research use only. Further terms were not disclosed. Magellan Biosciences Inc. , Chelmsford, Mass. miacom...
BioCentury | Jan 10, 2011
Company News

bioMerieux management update

bioMerieux S.A. (Euronext:BIM), Marcy l'Etoile, France Business: Diagnostic, Pharmacogenetics Hired: James Whelan as EVP of commercial services, formerly president of clinical diagnostics at Magellan Biosciences Inc. WIR Staff Diagnostic...
BioCentury | Mar 1, 2010
Company News

Magellan Bio management update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Hired: Hiroshi Uchida as president, CEO and a director, formerly EVP, CTO and a director at Fenwal Inc. WIR Staff Diagnostic...
BioCentury | Sep 28, 2009
Company News

Dionex, Magellan Bio deal

Magellan sold its ESA Life Sciences Tools business to laboratory instrument company Dionex. The deal includes ESA's high performance liquid chromatography (HPLC)-related products, HPLC assays, the ESA Laboratories services and assets and ESA's headquarters in...
BioCentury | Dec 24, 2007
Company News

Magellan Bio management update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Hired: Jasmine Gruia-Gray as VP of life sciences marketing of Magellan's ESA Biosciences Inc. unit, formerly director of marketing at Amersham plc 's Amersham Bioscience unit (now part...
BioCentury | Sep 3, 2007
Company News

Magellan Bio board of directors update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Appointed: Heiner Dreismann, former president and CEO of Roche 's Roche Molecular Diagnostics division; Laurence McCarthy, former president and CEO of Quest Diagnostics Corp.'s Focus Diagnostics Inc. subsidiary;...
BioCentury | Sep 3, 2007
Company News

Magellan Biosciences management update

Magellan Biosciences , Chelmsford, Mass. Business: Diagnostic Hired: Steven Diamond as CSO, formerly VP of R&D for point-of-care products at Siemens AG 's Siemens Medical Solutions Diagnostics unit WIR Staff Diagnostic...
BioCentury | May 14, 2007
Company News

Alderon Biosciences Inc., Magellan Bio deal

Magellan acquired undisclosed IP from Alderon for developing assays to detect metals, nucleic acids, proteins and small molecules. Magellan markets rapid point-of-care analyzers and automated systems for disease pathology and biomarker identification. Further terms were...
Items per page:
1 - 10 of 17
BioCentury | May 5, 2014
Company News

Magellan BioScience, Sirona Biochem deal

...financial terms will be determined on a project-basis. Magellan could not be reached for details. Magellan BioScience Group Inc....
BioCentury | Jul 25, 2011
Company News

Magellan Bio, Thermo Fisher deal

Magellan sold its TREK Diagnostic Systems to Thermo Fisher for an undisclosed sum. TREK includes automated blood culture, microbial identification and microbial susceptibility testing platforms. Magellan said it will focus on its LeadCare business, which...
BioCentury | Apr 18, 2011
Company News

Magellan Bio, miacom diagnostics GmbH sales and marketing update

Magellan received exclusive commercialization rights to miacom's Bacteremia and Fungimia panels in the U.S. and Canada to identify sepsis-related pathogens for research use only. Further terms were not disclosed. Magellan Biosciences Inc. , Chelmsford, Mass. miacom...
BioCentury | Jan 10, 2011
Company News

bioMerieux management update

bioMerieux S.A. (Euronext:BIM), Marcy l'Etoile, France Business: Diagnostic, Pharmacogenetics Hired: James Whelan as EVP of commercial services, formerly president of clinical diagnostics at Magellan Biosciences Inc. WIR Staff Diagnostic...
BioCentury | Mar 1, 2010
Company News

Magellan Bio management update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Hired: Hiroshi Uchida as president, CEO and a director, formerly EVP, CTO and a director at Fenwal Inc. WIR Staff Diagnostic...
BioCentury | Sep 28, 2009
Company News

Dionex, Magellan Bio deal

Magellan sold its ESA Life Sciences Tools business to laboratory instrument company Dionex. The deal includes ESA's high performance liquid chromatography (HPLC)-related products, HPLC assays, the ESA Laboratories services and assets and ESA's headquarters in...
BioCentury | Dec 24, 2007
Company News

Magellan Bio management update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Hired: Jasmine Gruia-Gray as VP of life sciences marketing of Magellan's ESA Biosciences Inc. unit, formerly director of marketing at Amersham plc 's Amersham Bioscience unit (now part...
BioCentury | Sep 3, 2007
Company News

Magellan Bio board of directors update

Magellan Biosciences Inc. , Chelmsford, Mass. Business: Diagnostic Appointed: Heiner Dreismann, former president and CEO of Roche 's Roche Molecular Diagnostics division; Laurence McCarthy, former president and CEO of Quest Diagnostics Corp.'s Focus Diagnostics Inc. subsidiary;...
BioCentury | Sep 3, 2007
Company News

Magellan Biosciences management update

Magellan Biosciences , Chelmsford, Mass. Business: Diagnostic Hired: Steven Diamond as CSO, formerly VP of R&D for point-of-care products at Siemens AG 's Siemens Medical Solutions Diagnostics unit WIR Staff Diagnostic...
BioCentury | May 14, 2007
Company News

Alderon Biosciences Inc., Magellan Bio deal

Magellan acquired undisclosed IP from Alderon for developing assays to detect metals, nucleic acids, proteins and small molecules. Magellan markets rapid point-of-care analyzers and automated systems for disease pathology and biomarker identification. Further terms were...
Items per page:
1 - 10 of 17